Clinical practice guidelines for uterine corpus cancer: an update to the Korean Society of Gynecologic Oncology guidelines
Journal of Gynecologic Oncology · 2025
DOI: 10.3802/jgo.2025.36.e71 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Gynecologic Oncology, 2025. Verfasst von Woo Yeon Hwang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, School of Medicine Kyung Hee University, Kyung Hee University Medical Center, Seoul, Korea. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Uterine Neoplasms. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Cancer Center.
Abstract (Originalsprache)
The Korean Society of Gynecologic Oncology has updated its clinical practice guidelines for endometrial cancer to incorporate advancements in recent high-quality randomized controlled trials. These guidelines address evolving treatment paradigms, and are tailored to the Korean medical context. Key updates include a strong recommendation for doxorubicin/trabectedin combination therapy in metastatic or recurrent unresectable leiomyosarcoma based on the significant survival benefits demonstrated in a randomized controlled trial. For advanced or recurrent endometrial cancer, immune checkpoint inhibitors combined with chemotherapy have received strong recommendations, owing to their proven efficacy and increased accessibility in Korea. Conditional recommendations were made for combination therapies involving durvalumab and olaparib, reflecting their potential benefits, but acknowledging regulatory and accessibility constraints. These guidelines aim to provide evidence-based, practical strategies to optimize care for patients with endometrial cancer while addressing unmet clinical needs and adapting global advancements to Korea's healthcare environment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, School of Medicine Kyung Hee University, Kyung Hee University Medical Center, Seoul, Korea.
- Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
- Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea.
- Department of Obstetrics and Gynecology, School of Medicine, Kangwon National University, Chuncheon, Korea.
- Comprehensive Gynecologic Cancer Center, CHA Bundang Medical Center, College of Medicine, CHA University, Seongnam, Korea.
- Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea.
ORCID-Profile: Woo Yeon Hwang, Ju-Hyun Kim, Joseph J Noh, Min-Hyun Baek, Min Chul Choi, Yong Jae Lee, Maria Lee, Dong Hoon Suh, Yong Beom Kim, Dae-Yeon Kim
Förderung
- National Cancer Center
Zitieren
APA
Hwang, W. Y., Kim, J. H., Noh, J. J., Baek, M. H., Choi, M. C., Lee, Y. J., Lee, M., Suh, D. H., Kim, Y. B., & Kim, D. Y. (2025). Clinical practice guidelines for uterine corpus cancer: an update to the Korean Society of Gynecologic Oncology guidelines. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2025.36.e71
Vancouver
Hwang WY, Kim JH, Noh JJ, Baek MH, Choi MC, Lee YJ, et al. Clinical practice guidelines for uterine corpus cancer: an update to the Korean Society of Gynecologic Oncology guidelines. Journal of Gynecologic Oncology. 2025. doi:10.3802/jgo.2025.36.e71
BibTeX
@article{Hwang2025,
author = {Hwang, Woo Yeon and Kim, Ju-Hyun and Noh, Joseph J and Baek, Min-Hyun and Choi, Min Chul and Lee, Yong Jae and Lee, Maria and Suh, Dong Hoon and Kim, Yong Beom and Kim, Dae-Yeon},
title = {Clinical practice guidelines for uterine corpus cancer: an update to the Korean Society of Gynecologic Oncology guidelines},
journal = {Journal of Gynecologic Oncology},
year = {2025},
doi = {10.3802/jgo.2025.36.e71}
}
EUVIMED